NCT05956821 2025-12-08Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of AgeUniversity of MiamiPhase 1/2 Recruiting20 enrolled
NCT05512351 2022-09-27Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse OligodendrogliomaHenan Provincial People's HospitalPhase 2 Recruiting80 enrolled